Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11161370 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma
Conditions: Lymphoblastic Leukemia;   Lymphoma
Intervention: Drug: Depocyte®

Indicates status has not been verified in more than two years